Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03737461
Previous Study | Return to List | Next Study

Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive (RESPINE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03737461
Recruitment Status : Recruiting
First Posted : November 9, 2018
Last Update Posted : April 10, 2020
Sponsor:
Collaborators:
Interdisziplinäres Zentrum Klinische Studien (IZKS)
European Clinical Research Infrastructure Network
Département de l'information médicale, CHU de Montpellier
Centre National de la Recherche Scientifique, France
Université Montpellier
Univercell-Biosolutions S.A.S
National University of Ireland, Galway, Ireland
University of Valladolid
Citospin
Rennes University Hospital
APHP
Campus Bio-Medico University
BG Klinikum Bergmannstrost, Halle, Germany
Nantes University Hospital
Institut de Terapia Regenerativa Tissular
University of Navarra
Information provided by (Responsible Party):
University Hospital, Montpellier

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2022